𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Optimal follow-up time to determine the sustained virological response in patients with chronic hepatitis C receiving pegylated-interferon and ribavirin

✍ Scribed by Masashi Namikawa; Satoru Kakizaki; Yutaka Yata; Yuichi Yamazaki; Norio Horiguchi; Ken Sato; Hitoshi Takagi; Masatomo Mori

Book ID
108954205
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
198 KB
Volume
27
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Twelve weeks posttreatment follow-up is
Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin
✍ Michelle Martinot-Peignoux; Christiane Stern; Sarah Maylin; Marie-Pierre Ripault πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 167 KB πŸ‘ 1 views

A sustained virologic response (SVR) in patients with chronic hepatitis C receiving pegylated interferon (PEG-IFN) plus ribavirin is defined as undetectable serum HCV-RNA at 24 weeks (W+24) posttreatment follow-up. Viral load outcome in patients with virological relapse (VR) has not been explored. T

Do steatosis and steatohepatitis impact
Do steatosis and steatohepatitis impact on sustained virological response (SVR) rates in patients receiving pegylated interferon and ribavirin for chronic hepatitis C infection?
✍ T.J.S. Cross; A. Quaglia; J. Nolan; S. Hughes; P.M. Harrison πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 1 views

## Abstract The impact of steatosis on treatment response in chronic hepatitis C infection is controversial. The aim of this study was to determine whether steatosis ± steatohepatitis on pre‐treatment liver biopsy influenced sustained virological response (HCV RNA negative 6 months after completing